BioSpace News Archive

TCR2 Therapeutics Inc., a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer, announced financial results for the third quarter ended September 30, 2019 and provided a corporate update.

Majority of patients completing 13 weeks of treatment demonstrated significant improvement on at least 2 measures of disease activity

IGM Biosciences, Inc., a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies for the treatment of cancer patients, announced that Fred Schwarzer, Chief Executive Officer, will present at three upcoming investor conferences

Applied Therapeutics, Inc. announced it has entered into a definitive securities purchase agreement, dated as of November 7, 2019, for the sale of its common stock, par value $0.0001 per share, in a private placement expected to result in gross proceeds to the Company of approximately $20 million, before deducting placement agent commissions and other offering expenses.

RedHill Biopharma Ltd. announced the publication of results from the Company’s Phase 3 study with RHB-102 1 in acute gastroenteritis in the Journal of the American Medical Association Network Open.

BD, a leading global medical technology company, announced that it has submitted a pre-market approval supplement to the U.S. Food and Drug Administration for an expanded version of its BD Onclarity™ HPV Assay.

Akero Therapeutics, Inc. reported third quarter 2019 financial results for the period ending September 30, 2019.

Sorrento Therapeutics, Inc., announced that Dr. Henry Ji, Chairman and CEO, will participate in upcoming investor conferences in the 4th quarter 2019.

Moleculin Biotech, Inc.,, a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, announced its financial results for the third quarter ended September 30, 2019.

Intec Pharma Ltd. announces financial results for the three and nine months ended September 30, 2019.